In the future, the focus should be on its reproductive safety, long-term efficacy, and integration with other therapies, ultimately achieving effective transformation from basic research to clinical practice
10.1101/cshperspect.a004424 104
That does not establish a universal clinical outcome for every human patient
In a murine model of AD, melatonin diminished GSK3 activity [61], an effect potentially reliant on melatonin receptor MT1, as implied by findings in SH-SY5Y cells [62]
Obviamente en ningn momento de la dieta estaremos 84h en ayunas, pero nos podemos hacer una idea de que nuestro cuerpo tolera el estar sin ingerir alimentos durante ms de 5 horas sin tener repercusiones
It is currently in Phase 3 clinical trials, and approval is not expected for at least another 1-2 years at the earliest